Carolyn J Presley, MD
Academic Title: Associate Professor in the College of Medicine
Research Program: Cancer Control
About Me
More info forI am an Associate Professor on the tenure track in the Division of Medical Oncology/Department of Internal Medicine at The Ohio State University, Comprehensive Cancer Center and The James Cancer Hospital/Solove Research Institute. I earned my undergraduate degree from the University of Minnesota, Twin Cities and my medical degree from Dartmouth Medical School. I completed residency in Internal Medicine and combined fellowship in Geriatric Oncology and Hematology at Yale University. I completed a Masters in Health Sciences, also at Yale, within the Robert Wood Johnson Foundation Clinical Scholars Program sponsored by the VA Connecticut Healthcare System. I am an active member of the Ohio State University Comprehensive Cancer Program, The American Geriatrics Society, and the American Society of Clinical Oncology. I have been a long-time member of the international Cancer and Aging Research Group (CARG). I currently leads studies focused on maintaining functional independence among older adults with lung cancer. These studies incorporate geriatric assessment, embedded palliative care, and interventions to improve risk factors for treatment toxicity and functional decline. I have been funded by the National Institute of Aging, the BMS Foundation, the Rising Tide Foundation, and am one of the first two women to ever receive the preeminent Paul Beeson Emerging Leaders in Aging Career Development Award at OSU and this month I received the National LEAD Rising Star Award for Women in hematology and oncology.
Clinical Expertise
More info for- Lung Cancers
- Lung Cancers
- Mesothelioma
Where I See Patients
More info forEducation & Training
More info forMedical School
- Geisel School Of Medicine At Dartmouth
1 Rope Ferry Rd, Hanover, NH
Fellowship - Geriatric Medicine
- Yale-New Haven Hospital of St. Raphael
1450 Chapel St, New Haven, CT
Fellowship - Medical Oncology
- Yale-New Haven Hospital of St. Raphael
1450 Chapel St, New Haven, CT
Internship - Internal Medicine
- Yale-New Haven Hospital of St. Raphael
1450 Chapel St, New Haven, CT
Residency - Internal Medicine
- Yale-New Haven Hospital of St. Raphael
1450 Chapel St, New Haven, CT
- Geisel School Of Medicine At Dartmouth
Academic Office & Contact Information
More info forAcademic Office:
Lincoln Tower 1335
1800 Cannon Dr
Columbus, Ohio 43210Email:
presley.53@osu.eduReviews
More info forPatient Satisfaction Review
The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our
Patient Satisfaction Survey page The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.
Publications
More info forSeptember 26, 2024Lung cancer patients' illness perceptions: Prognostic for psychological and physical health trajectories.
Valentine TR, Park KR, Presley CJ, Shields PG, Andersen BL
Health Psychology
September 18, 2024Strength of Evidence Underlying the CMS-FDA Parallel Review of Comprehensive Genomic Profiling Tests in the Cancer Setting.
Stackland S, Schnabel D, Dinan M, Presley CJ, Gross CP
J Natl Cancer Inst
September 16, 2024Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort study.
Singhal S, Walter LC, Smith AK, Boscardin WJ, Shi Y, Cohen HJ, Presley CJ, Kushi LH, Giri S, Magnuson A, Williams GR, Velazquez AI, Lee HJ, Sakoda LC, Quesenberry CP, Falvey JR, Van Dyk KM, Wong ML
J Geriatr Oncol
September 12, 2024Improved survival for patients with lung cancer treated with perioperative immunotherapy.
Presley CJ, Owen DH
Lancet
September 7, 2024Functional resilience and overall survival in adults treated for advanced non-small-cell lung cancer.
Presley CJ, Tang J, Benedict J, Grogan M, Reisinger S, Janse S, Wong ML, Arrato NA, Davenport A, Shields PG, Andersen BL
Lung Cancer
September 1, 2024A video intervention to improve patient understanding of tumor genomic testing in patients with cancer.
Veney DJ, Wei LY, Toland AE, Presley CJ, Hampel HL, Padamsee TJ, Lee CN, Irvin WJ, Bishop MJ, Kim JJ, Hovick SR, Senter LA, Stover DG
Cancer Med
August 21, 2024Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancer.
Presley CJ, Grogan M, Compston A, Hock K, Knauss B, Redder E, Arrato NA, Lo SB, Janse S, Benedict J, Hoyd R, Williams N, Hayes S, Wells-Di Gregorio S, Gill TM, Allore H, Focht B, Quist M, Carbone DP, Spakowicz D, Paskett ED, Andersen BL
J Geriatr Oncol
August 6, 2024Practical Insights from Integrating Financial Hardship Screening at a Comprehensive Cancer Center.
Obeng-Gyasi S, Gokun Y, Presley CJ, Rosko A, Plascak J, Paskett ED
J Am Coll Radiol
July 10, 2024Prehabilitation for Older Adults Undergoing Lung Cancer Surgery: A Literature Review and Needs Assessment.
Zhao JY, Presley C, Madariaga ML, Ferguson M, Merritt RE, Kneuertz PJ
Clin Lung Cancer
June 13, 2024A theoretical explanation for how a nutrition counseling and medically tailored meal delivery program benefitted participants living with lung cancer.
Rothpletz-Puglia P, Smith J, Pavuk C, Leotta J, Pike K, Presley CJ, Krok-Schoen JL, Braun A, Cohen MK, Rogers GT, Chui KKH, Zhang FF, Spees CK
Support Care Cancer
June 3, 2024Safety and Efficacy Outcomes of Early Cessation of Anti-PD1 Therapy in Patients 80 Years or Older: A Retrospective Cohort Study.
Fletcher K, Cortellini A, Ganta T, Kankaria R, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Presley CJ, Owen DH, Abou Alaiwi S, Nassar AH, Lamberti G, Perrone F, Buti S, Giusti R, Filetti M, Vanella V, Mallardo D, Sussman TA, Galetta D, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Nebhan C, Berg S, Choueiri TK, Marron TU, Wang Y, Naqash AR, Johnson DB
Cancer Lett
June 1, 2024Survivorship in Advanced Lung Cancer: Understanding a New Landscape and Opportunities.
Presley CJ, Dalal N, Davenport AP, Gounden A, Ramchandran K, Tonorezos E
Am Soc Clin Oncol Educ Book
April 28, 2024Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy.
Rosko AE, Elsaid MI, Woyach J, Islam N, Lepola N, Urrutia J, Christian LM, Presley C, Mims A, Burd CE
J Cancer Surviv
April 5, 2024HSR24-160: Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus: Patient Characteristics, Clinical Outcomes, and Survival Implications of Autoantibodies.
Sharp J, Pasadyn C, Zhao S, Wei L, Presley C, Owen D, Wyne K, Meara A
J Natl Compr Canc Netw
April 5, 2024CLO24-061: Overall Survival (OS) Impact for NSCLC Patients With irAE and Non-irAE Hospital Admissions During First-Line Pembrolizumab Treatment.
Khorasanchi A, Zhao S, Wei L, Li M, Ho K, Abu-Sbeih H, Goodyear E, Secor A, Shields P, He K, Kaufman J, Memmott R, Alahmadi A, Carbone D, Otterson G, Meara A, Presley C, Owen D
J Natl Compr Canc Netw
April 1, 2024Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer.
Gupta A, Nguyen P, Kain D, Robinson AG, Kulkarni AA, Johnson DH, Presley CJ, Blaes AH, Rocque GB, Ganguli I, Booth CM, Hanna TP
JAMA Netw Open
February 20, 2024A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.
Williams TM, Miller E, Welliver M, Brownstein J, Otterson G, Owen D, Haglund K, Shields P, Bertino E, Presley C, He K, Naduparambil J, Walston S, Pan J, Yang X, Knopp M, Essan JK, McElroy J, Mo X, McElroy S, Carbone D, Bazan J
Int J Radiat Oncol Biol Phys
February 15, 2024Lung cancer screening use among screening-eligible adults with disabilities.
Poghosyan H, Richman I, Sarkar S, Presley CJ
J Am Geriatr Soc
January 1, 2024The FITNESS study: longitudinal geriatric assessment, treatment toxicity, and biospecimen collection to assess functional disability among older adults with lung cancer.
Grogan M, Hoyd R, Benedict J, Janse S, Williams N, Naughton M, Burd CE, Paskett ED, Rosko A, Spakowicz DJ, Presley CJ
Front Aging
November 13, 2023Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
Burns L, Hsu CY, Whisenant JG, Marmarelis ME, Presley CJ, Reckamp KL, Khan H, Jo Fidler M, Bestvina CM, Brahmer J, Puri S, Patel JD, Halmos B, Hirsch FR, Liu SV, Costa DB, Goldberg SB, Feldman LE, Mamdani H, Puc M, Mansfield AS, Islam N, Scilla KA, Garassino MC, Horn L, Peters S, Wakelee HA, Charlot M, Tapan U
Lung Cancer
November 1, 2023Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.
Wong A, Riley M, Zhao S, Zimmer J, Viveiros M, Wang JG, Esguerra V, Li M, Lopez G, Kendra K, Carbone DP, He K, Alahmadi A, Kaufman J, Memmott RM, Shields PG, Brownstein J, Haglund K, Welliver M, Otterson GA, Presley CJ, Wei L, Owen DH, Ho K
J Natl Compr Canc Netw
September 5, 2023Changes in physical function in older women with endometrial cancer with or without adjuvant therapy.
Quick AM, McLaughlin E, Krok Schoen JL, Felix AS, Presley CJ, Cespedes Feliciano EM, Shadyab AH, Jung SY, Luo J, King JJ, Rapp SR, Werts S, Chlebowski RT, Naughton M, Paskett E
J Cancer Surviv
June 6, 2023Improving Access to Early Palliative Care Delivery for Patients With an Advanced Thoracic Malignancy Through an Embedded Oncopalliative Clinic Model.
Agne JL, Bertino EM, Gast K, Grogan MM, Janse S, Benedict J, Presley CJ
JCO Oncol Pract
June 1, 2023Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancer.
Singhi EK, Mott F, Worst M, Leung CH, Lee JJ, Carter B, Presley CJ, Heymach JV, Altan M
Oncol Lett
April 21, 2023Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Johns AC, Yang M, Wei L, Grogan M, Spakowicz D, Patel SH, Li M, Husain M, Kendra KL, Otterson GA, Rosko AE, Andersen BL, Carbone DP, Owen DH, Presley CJ
Oncologist
March 1, 2023Estimating Cancer Treatment Tolerability for Older Adults With Advanced Cancer-The Holy Grail.
Presley CJ
JAMA Netw Open
October 3, 2022End-of-life care trajectories among older adults with lung cancer.
Davidoff AJ, Canavan ME, Prsic E, Saphire M, Wang SY, Presley CJ
J Geriatr Oncol
September 21, 2022Patient Understanding of Tumor Genomic Testing: A Quality Improvement Effort.
Senter L, Veney D, Surplus T, Haynam M, Adams EJ, Hampel H, Toland AE, Presley CJ, Padamsee TJ, Lee CN, Hovick SR, Stover DG
JCO Oncol Pract
September 7, 2022Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
Miah A, Tinoco G, Zhao S, Wei L, Johns A, Patel S, Li M, Grogan M, Lopez G, Husain M, Hoyd R, Mumtaz K, Meara A, Bertino EM, Kendra K, Spakowicz D, Otterson GA, Presley CJ, Owen DH
J Cancer Res Clin Oncol
September 7, 2022Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors.
Matsui JK, Perlow HK, Raj RK, Nalin AP, Lehrer EJ, Kotecha R, Trifiletti DM, McClelland S, Kendra K, Williams N, Owen DH, Presley CJ, Thomas EM, Beyer SJ, Blakaj DM, Ahluwalia MS, Raval RR, Palmer JD
Biomedicines
September 1, 2022Change in four measures of physical function among older adults during lung cancer treatment: A mixed methods cohort study.
Singhal S, Walter LC, Smith AK, Loh KP, Cohen HJ, Zeng S, Shi Y, Boscardin WJ, Presley CJ, Williams GR, Magnuson A, Mohile SG, Wong ML
J Geriatr Oncol
July 4, 2022Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer.
Issa M, Tang J, Guo Y, Coss C, Mace TA, Bischof J, Phelps M, Presley CJ, Owen DH
Expert Rev Anticancer Ther
July 1, 2022Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer.
Obeng-Gyasi S, Li Y, Carson WE, Reisenger S, Presley CJ, Shields PG, Carbone DP, Ceppa DP, Carlos RC, Andersen BL
JAMA Netw Open
June 16, 2022Characterization of older adults with cancer seeking acute emergency department care: A prospective observational study.
Bischof JJ, Elsaid MI, Bridges JFP, Rosko AE, Presley CJ, Abar B, Adler D, Bastani A, Baugh CW, Bernstein SL, Coyne CJ, Durham DD, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR, Venkat A, Wilson J, Yeung SJ, Yilmaz S, Caterino JM
J Geriatr Oncol
June 1, 2022Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer.
Valentine TR, Presley CJ, Carbone DP, Shields PG, Andersen BL
Health Psychology
June 1, 2022Functional Trajectories and Resilience Among Adults With Advanced Lung Cancer.
Presley CJ, Arrato NA, Shields PG, Carbone DP, Wong ML, Benedict J, Reisinger SA, Han L, Gill TM, Allore H, Andersen BL, Janse S
JTO Clin Res Rep
May 20, 2022COVID-19 Outcomes, Patient Vaccination Status, and Cancer-Related Delays during the Omicron Wave: A Brief Report from the TERAVOLT Analysis.
Bestvina CM, Whisenant JG, Torri V, Cortellini A, Wakelee H, Peters S, Roca E, De Toma A, Hirsch FR, Mamdani H, Halmos B, Arrieta O, Metivier AC, Fidler MJ, Rogado J, Presley CJ, Mascaux C, Genova C, Blaquier JB, Addeo A, Finocchiaro G, Khan H, Mazieres J, Morgillo F, Bar J, Aujayeb A, Mountzios G, Scotti V, Grosso F, Geraedts E, Zhumagaliyeva AN, Horn L, Garassino MC, Baena J, TERAVOLT study group
JTO Clin Res Rep
March 30, 2022Aggressive End-of-Life Care in the Veterans Health Administration versus Fee-for-Service Medicare among Patients with Advanced Lung Cancer.
Presley CJ, Kaur K, Han L, Soulos PR, Zhu W, Corneau E, O'Leary JR, Chao H, Shamas T, Rose MG, Lorenz KA, Levy CR, Mor V, Gross CP
J Palliat Med
February 25, 2022Polypharmacy in older adults with cancer undergoing radiotherapy: A review.
Novak J, Goldberg A, Dharmarajan K, Amini A, Maggiore RJ, Presley CJ, Nightingale G
J Geriatr Oncol
February 1, 2022Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non-Small Cell Lung Cancer Versus Community Controls.
Arrato NA, Lo SB, Coker CA, Covarrubias JJ, Blevins TR, Reisinger SA, Presley CJ, Shields PG, Andersen BL
J Natl Compr Canc Netw
January 31, 2022Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer.
Altan M, Singhi EK, Worst M, Carter BW, Leung CH, Lee JJ, Presley CJ, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Zhang J, Gibbons DL, Vaporciyan AA, Heymach JV, Mott FE
Clin Lung Cancer
January 24, 2022A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry.
Whisenant JG, Baena J, Cortellini A, Huang LC, Lo Russo G, Porcu L, Wong SK, Bestvina CM, Hellmann MD, Roca E, Rizvi H, Monnet I, Boudjemaa A, Rogado J, Pasello G, Leighl NB, Arrieta O, Aujayeb A, Batra U, Azzam AY, Unk M, Azab MA, Zhumagaliyeva AN, Gomez-Martin C, Blaquier JB, Geraedts E, Mountzios G, Serrano-Montero G, Reinmuth N, Coate L, Marmarelis M, Presley CJ, Hirsch FR, Garrido P, Khan H, Baggi A, Mascaux C, Halmos B, Ceresoli GL, Fidler MJ, Scotti V, Métivier AC, Falchero L, Felip E, Genova C, Mazieres J, Tapan U, Brahmer J, Bria E, Puri S, Popat S, Reckamp KL, Morgillo F, Nadal E, Mazzoni F, Agustoni F, Bar J, Grosso F, Avrillon V, Patel JD, Gomes F, Ibrahim E, Trama A, Bettini AC, Barlesi F, Dingemans AM, Wakelee H, Peters S, Horn L, Garassino MC, Torri V, TERAVOLT study group
J Thorac Oncol
January 8, 2022Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.
Guo Y, Wei L, Patel SH, Lopez G, Grogan M, Li M, Haddad T, Johns A, Ganesan LP, Yang Y, Spakowicz DJ, Shields PG, He K, Bertino EM, Otterson GA, Carbone DP, Presley C, Kulp SK, Mace TA, Coss CC, Phelps MA, Owen DH
Clin Lung Cancer
January 1, 2022Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy.
Gast KC, Benedict JA, Grogan M, Janse S, Saphire M, Kumar P, Bertino EM, Agne JL, Presley CJ
Front Oncol
January 1, 2022A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial.
Presley CJ, Mohamed MR, Culakova E, Flannery M, Vibhakar PH, Hoyd R, Amini A, VanderWalde N, Wong ML, Tsubata Y, Spakowicz DJ, Mohile SG
Front Oncol
January 1, 2022Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.
Chennamadhavuni A, Abushahin L, Jin N, Presley CJ, Manne A
Front Immunol
November 4, 2021Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
Nebhan CA, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley CJ, Owen DH, Abou Alaiwi S, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman TA, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Dal Bello MG, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Choueiri TK, Johnson DB, Marron TU, Wang Y, Naqash AR
JAMA Oncol
November 1, 2021A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC).
Williams TM, Welliver MX, Brownstein JM, Otterson G, Owen D, Pan J, Haglund KE, Shields PG, Bertino EM, Presley C, He K, Miller ED, Yang X, Knopp M, Essan JK, McElroy S, Carbone DP, Bazan JG
Int J Radiat Oncol Biol Phys
October 9, 2021Psychological Symptom Trajectories and Non-Small Cell Lung Cancer Survival: A Joint Model Analysis.
Andersen BL, McElroy JP, Carbone DP, Presley CJ, Smith RM, Shields PG, Brock GN
Psychosomatic Medicine
October 7, 2021Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Haddad TC, Zhao S, Li M, Patel SH, Johns A, Grogan M, Lopez G, Miah A, Wei L, Tinoco G, Riesenberg B, Li Z, Meara A, Bertino EM, Kendra K, Otterson G, Presley CJ, Owen DH
Cancer Immunol Immunother
October 5, 2021Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study.
Wong ML, Shi Y, Smith AK, Miaskowski C, Boscardin WJ, Cohen HJ, Lam V, Mazor M, Metzger L, Presley CJ, Williams GR, Loh KP, Ursem CJ, Friedlander TW, Blakely CM, Gubens MA, Allen G, Shumay D, Walter LC
J Am Geriatr Soc
August 23, 2021Bayesian structural time series for biomedical sensor data: A flexible modeling framework for evaluating interventions.
Liu J, Spakowicz DJ, Ash GI, Hoyd R, Ahluwalia R, Zhang A, Lou S, Lee D, Zhang J, Presley C, Greene A, Stults-Kolehmainen M, Nally LM, Baker JS, Fucito LM, Weinzimer SA, Papachristos AV, Gerstein M
PLoS Comput Biol
August 23, 2021Feasibility of implementing an exercise intervention in older adults with hematologic malignancy.
Rosko A, Huang Y, Jones D, Presley CJ, Jaggers J, Owens R, Naughton M, Krok-Schoen JL
J Geriatr Oncol
August 13, 2021Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical Practice.
Edelman MJ, Raymond DP, Owen DH, Leavy MB, Chansky K, Yennu S, Fernandez FG, Presley CJ, Biswas T, Quinn GP, Schabath MB, Sheffler-Collins S, Chu L, Gliklich RE
J Natl Compr Canc Netw
May 27, 2021Immunotherapy in Older Adults With Cancer.
Presley CJ, Gomes F, Burd CE, Kanesvaran R, Wong ML
J Clin Oncol
May 19, 2021Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care.
Kumar PS, Saphire ML, Grogan M, Benedict J, Janse S, Agne JL, Bertino EM, Presley CJ
J Pain Palliat Care Pharmacother
May 3, 2021Functional Disability Among Older Versus Younger Adults With Advanced Non-Small-Cell Lung Cancer.
Presley CJ, Arrato NA, Janse S, Shields PG, Carbone DP, Wong ML, Han L, Gill TM, Allore HG, Andersen BL
JCO Oncol Pract
April 20, 2021Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Qin A, Zhao S, Miah A, Wei L, Patel S, Johns A, Grogan M, Bertino EM, He K, Shields PG, Kalemkerian GP, Gadgeel SM, Ramnath N, Schneider BJ, Hassan KA, Szerlip N, Chopra Z, Journey S, Waninger J, Spakowicz D, Carbone DP, Presley CJ, Otterson GA, Green MD, Owen DH
J Natl Compr Canc Netw
April 15, 2021Characteristics Associated With Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults.
Loh KP, Lam V, Webber K, Padam S, Sedrak MS, Musinipally V, Grogan M, Presley CJ, Grandi J, Sanapala C, Castillo DA, DiGiovanni G, Mohile SG, Walter LC, Wong ML
J Natl Compr Canc Netw
March 1, 2021Care Disparities Across the Health Care Continuum for Older Adults: Lessons From Multidisciplinary Perspectives.
Dharmarajan KV, Presley CJ, Wyld L
Am Soc Clin Oncol Educ Book
February 24, 2021Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events.
Nashed A, Zhang S, Chiang CW, Zitu M, Otterson GA, Presley CJ, Kendra K, Patel SH, Johns A, Li M, Grogan M, Lopez G, Owen DH, Li L
Cancer Immunol Immunother
February 21, 2021Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer.
Johns AC, Wei L, Grogan M, Hoyd R, Bridges JFP, Patel SH, Li M, Husain M, Kendra KL, Otterson GA, Burkart JT, Rosko AE, Andersen BL, Carbone DP, Owen DH, Spakowicz DJ, Presley CJ
J Geriatr Oncol
February 18, 2021The aging microbiome and response to immunotherapy: Considerations for the treatment of older adults with cancer.
Spakowicz D, Bibi A, Muniak M, Williams NF, Hoyd R, Presley CJ
J Geriatr Oncol
February 11, 2021Line of therapy and patient preferences regarding lung cancer treatment: A discrete-choice experiment.
Janse S, Janssen E, Huwig T, Basu Roy U, Ferris A, Presley CJ, Bridges JF
Curr Med Res Opin
January 3, 2021End-of-life patterns of symptom management and cancer-directed care among Medicare beneficiaries with lung cancer: a claims-based analysis.
Davidoff AJ, Canavan ME, Prsic E, Saphire M, Wang SY, Presley CJ
Support Care Cancer
January 1, 2021Too Many Appointments: Assessing Provider and Nursing Perception of Barriers to Referral for Outpatient Palliative Care.
Agne JL, Bertino EM, Grogan M, Benedict J, Janse S, Naughton M, Eastep C, Callahan M, Presley CJ
Palliat Med Rep
January 1, 2021Integration of a Geriatric Assessment With Intervention in the Care of Older Adults With Hematologic Malignancies.
Wall SA, Huang Y, Keiter A, Funderburg A, Kloock C, Yuhasz N, Gure TR, Folefac E, Stevens E, Presley CJ, Williams NO, Krok-Schoen JL, Naughton MJ, Rosko AE
Front Oncol
July 29, 2020Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.
Li M, Spakowicz D, Zhao S, Patel SH, Johns A, Grogan M, Miah A, Husain M, He K, Bertino EM, Shields PG, Wei L, Carbone DP, Otterson GA, Presley CJ, Owen DH
Cancer Immunol Immunother
July 27, 2020Integration of geriatric assessment into routine oncologic care and advances in geriatric oncology: A young International Society of Geriatric Oncology Report of the 2020 American Society of Clinical Oncology (ASCO) annual meeting.
Giri S, Chakiba C, Shih YY, Chan WL, Krok-Schoen JL, Presley CJ, Williams GR, Subbiah IM
J Geriatr Oncol
July 17, 2020Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of Life.
Riaz F, Gan G, Li F, Davidoff AJ, Adelson KB, Presley CJ, Adamson BJ, Shaw P, Parikh RB, Mamtani R, Gross CP
JCO Oncol Pract
July 6, 2020Implementing a multidisciplinary approach for older adults with Cancer: geriatric oncology in practice.
Presley CJ, Krok-Schoen JL, Wall SA, Noonan AM, Jones DC, Folefac E, Williams N, Overcash J, Rosko AE
BMC Geriatr
June 1, 2020Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer.
Leapman MS, Presley CJ, Zhu W, Soulos PR, Adelson KB, Miksad RA, Boffa DJ, Gross CP
JAMA Netw Open
May 29, 2020Multidisciplinary telemedicine and the importance of being seen.
Wall SA, Knauss B, Compston A, Redder E, Folefac E, Presley C, Rosko A
J Geriatr Oncol
May 6, 2020Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
Spakowicz D, Hoyd R, Muniak M, Husain M, Bassett JS, Wang L, Tinoco G, Patel SH, Burkart J, Miah A, Li M, Johns A, Grogan M, Carbone DP, Verschraegen CF, Kendra KL, Otterson GA, Li L, Presley CJ, Owen DH
BMC Cancer
Consulting and Related Relationships
More info forAt The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Presley has reported no relationships with companies or entities.
Patient Comments
Always seemed to care about my situations
I trust Dr Presley and I feel very comfortable asking her questions. She is very caring and takes the time to explain my scan results and she answers my questions fully. She definitely is an integral part in my cancer care.
Good
She was awesome about explaining things and answering questions
Everything was good
Forgive me, I don't recall the PA's name, but she provided helpful information during my visit. Carolyn was wonderfuI, I feel I received her time and consideration. The advice for which I traveled a thousand miles for and occurred additional cost.
The medical care I have received has been excellent.
Good
Care givers are excellent I am very fortunate to be treated here.
Dr. Presley is beyond excellent.
Could not have been more pleased with the care provided.
Dr Presley and her staff go the extra mile and contact radiologist to clarify confusing CT scan report and request more detailed information.